Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |